Skip to content

The effect of Avastin on posterior capsular opacification after phacoemulsification: a randomized controlled trial

The effect of Avastin on posterior capsular opacification after phacoemulsification: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017032531450N4
Enrollment
60
Registered
2017-07-25
Start date
2016-03-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract. H28*

Interventions

Intervention 1: After the surgical treatment, the Avastin will be injected into the posterior lens aqueous humor. Intervention 2: After the surgical treatment, the BSS will be injected into the poster
Treatment - Drugs
After the surgical treatment, the Avastin will be injected into the posterior lens aqueous humor
After the surgical treatment, the BSS will be injected into the posterior lens aqueous humor

Sponsors

Vice Chancellor for research of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion: Cataract patients undergoing surgical treatment for cataract in both eyes using phacoemulsification method. Exclusion: Eye trauma eye disease previous history of uveitis and collagen vascular diseases. Diabetic patients were removed from study to avoid bias.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Posterior lens capsule opacification after cataract surgery in patients with Avastin injection. Timepoint: Before the intervention, one month after the intervention and six months after the intervention and one year after the intervention. Method of measurement: Using the model PENTACAM OCULUS and densitometry DYSPLAY as little to check the status of posterior capsule opacification.;Posterior lens capsule opacification after cataract surgery in patients with BSS injection. Timepoint: Before the intervention, one month after the intervention and six months after the intervention and one year after the intervention. Method of measurement: ????? ????? ???? ??? ??? ?? ??? ????? ???????? ?? ??????? ?? ????? BSS.

Secondary

MeasureTime frame
Posterior lens capsule opacification after cataract surgery in patients with Avastin injection. Timepoint: Before the intervention, one month after the intervention and six months after the intervention and one year after the intervention. Method of measurement: Using the model PENTACAM OCULUS and densitometry DYSPLAY as little to check the status of posterior capsule opacification.;Posterior lens capsule opacification after cataract surgery in patients with BSS injection. Timepoint: Before the intervention, one month after the intervention and six months after the intervention and one year after the intervention. Method of measurement: Using the model PENTACAM OCULUS and densitometry DYSPLAY as little to check the status of posterior capsule opacification.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sabuhe Ghorbani ( Ophthalmology Assistant)

Tabriz University of Medical Sciences

sgb.umu82@yahoo.com+98 41 3657 1670

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026